EYES2022 ESE Young Endocrinologists and Scientists (EYES) 2022 Adrenal and Cardiovascular (12 abstracts)
1Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Centre of Serbia, National Centre for Infertility and Endocrinology of Gender; 2University of Belgrade, Serbia, Faculty of Medicine; 3University of Belgrade, Serbia, School of Electrical Engineering
Background: Recent studies showed that cortisol autonomy is age and sex dependent and highly associated with higher all-cause mortality in patients with adrenal incidentalomas (AI). Dehydroepiandrosterone sulphate (DHEAS) has been recognized as a valuable diagnostic tool in patients with (possible) autonomous cortisol secretion.
Objectives: As DHEAS levels are sex and age specific we aimed to evaluate its value as a diagnostic tool in patients with adrenal incidentalomas.
Methods: We evaluated 306 patients, the mean age was 59.8 ± 9.6 years, 95 men aged 60.05 ± 9.59 and 211 women aged 59.74 ± 9.65 years. Based on average menopause age of 51, we stratified women in two groups: < 51 and ≥ 51. For the sake of comparison, we age-matched the male group.
Results: The area under the receiver operating characteristic (AUC-ROC) curve for detection of mild cortisol excess in men was 0.65 (95% CI, 0.539 0.760, P = 0.012) with a cutoff value of 2.45 μmol/l. In women the AUC-ROC curve was 0.68 (95% CI, 0.610-0.753, P = 0.000) with a cutoff value of 1.27 μmol/l. However, DHEAS lost its significance as a diagnostic tool in age specific groups in men. Whereas, in women, there was an age specific difference between the groups: in women <51 years old the AUC-ROC curve was 0.72 (95% CI, 0.558-0.896, P = 0.022) with a cutoff value of 1.85 μmol/l and in women ≥ 51 years old the AUC-ROC curve was 0.67 (95% CI, 0.595-0.752, P = 0.000) with a cutoff value of 1.05 μmol/l.
Conclusion: DHEAS is a reliable sex specific diagnostic tool for detection of mild cortisol excess but in female patients DHEAS is also age specific.